After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

California is leading the way in ensuring that determinations of medically necessary health care services are made by licensed physicians and ...

CEO David Cordani suggested Thursday that the moves are a direct response to the slaying of UnitedHealthcare CEO Brian Thompson and the public outcry over the state of health care. Other news is on ...

The victim count from last year's data breach has increased significantly. The number of victims impacted by the Change ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Cigna (CI – Research Report), with a price target of ...

Erin Wright, an analyst from Morgan Stanley, assigned the Buy rating on Cigna (CI – Research Report). The associated price target is ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

Shares of Cigna Group slipped 6.70% to $282.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,071.17 and the Dow ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...